These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27841268)

  • 1. Hallucinations and conscious access to visual inputs in Parkinson's disease.
    Lefebvre S; Baille G; Jardri R; Plomhause L; Szaffarczyk S; Defebvre L; Thomas P; Delmaire C; Pins D; Dujardin K
    Sci Rep; 2016 Nov; 6():36284. PubMed ID: 27841268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired visual processing preceding image recognition in Parkinson's disease patients with visual hallucinations.
    Meppelink AM; de Jong BM; Renken R; Leenders KL; Cornelissen FW; van Laar T
    Brain; 2009 Nov; 132(Pt 11):2980-93. PubMed ID: 19755518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations.
    Goldman JG; Stebbins GT; Dinh V; Bernard B; Merkitch D; deToledo-Morrell L; Goetz CG
    Brain; 2014 Mar; 137(Pt 3):849-59. PubMed ID: 24480486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing an aetiological model of visual hallucinations in Parkinson's disease.
    Gallagher DA; Parkkinen L; O'Sullivan SS; Spratt A; Shah A; Davey CC; Bremner FD; Revesz T; Williams DR; Lees AJ; Schrag A
    Brain; 2011 Nov; 134(Pt 11):3299-309. PubMed ID: 21921019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flickering Stimuli Do Not Reliably Induce Visual Hallucinations in Parkinson's Disease.
    Zarkali A; Lees AJ; Weil RS
    J Parkinsons Dis; 2019; 9(3):631-635. PubMed ID: 31227657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attention and visual dysfunction in Parkinson's disease.
    Botha H; Carr J
    Parkinsonism Relat Disord; 2012 Jul; 18(6):742-7. PubMed ID: 22503538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant functional connectivity of resting state networks related to misperceptions and intra-individual variability in Parkinson's disease.
    Miloserdov K; Schmidt-Samoa C; Williams K; Weinrich CA; Kagan I; Bürk K; Trenkwalder C; Bähr M; Wilke M
    Neuroimage Clin; 2020; 25():102076. PubMed ID: 31794926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pareidolia in Parkinson's disease without dementia: A positron emission tomography study.
    Uchiyama M; Nishio Y; Yokoi K; Hosokai Y; Takeda A; Mori E
    Parkinsonism Relat Disord; 2015 Jun; 21(6):603-9. PubMed ID: 25864093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual Priming and Visual Hallucinations in Parkinson's Disease. Evidence for Normal Top-Down Processes.
    Straughan S; Collerton D; Bruce V
    J Geriatr Psychiatry Neurol; 2016 Jan; 29(1):25-30. PubMed ID: 26232406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lateral geniculate atrophy in Parkinson's with visual hallucination: A trans-synaptic degeneration?
    Lee JY; Yoon EJ; Lee WW; Kim YK; Lee JY; Jeon B
    Mov Disord; 2016 Apr; 31(4):547-54. PubMed ID: 26846525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. I finally see what you see: Parkinson's disease visual hallucinations captured with functional neuroimaging.
    Goetz CG; Vaughan CL; Goldman JG; Stebbins GT
    Mov Disord; 2014 Jan; 29(1):115-7. PubMed ID: 23843193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imagine that: elevated sensory strength of mental imagery in individuals with Parkinson's disease and visual hallucinations.
    Shine JM; Keogh R; O'Callaghan C; Muller AJ; Lewis SJ; Pearson J
    Proc Biol Sci; 2015 Jan; 282(1798):20142047. PubMed ID: 25429016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reality monitoring and visual hallucinations in Parkinson's disease.
    Barnes J; Boubert L; Harris J; Lee A; David AS
    Neuropsychologia; 2003; 41(5):565-74. PubMed ID: 12559149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral atrophy in Parkinson's disease patients with visual hallucinations.
    Ramírez-Ruiz B; Martí MJ; Tolosa E; Giménez M; Bargalló N; Valldeoriola F; Junqué C
    Eur J Neurol; 2007 Jul; 14(7):750-6. PubMed ID: 17594330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in network controllability and regional gene expression underlie hallucinations in Parkinson's disease.
    Zarkali A; McColgan P; Ryten M; Reynolds R; Leyland LA; Lees AJ; Rees G; Weil RS
    Brain; 2020 Dec; 143(11):3435-3448. PubMed ID: 33118028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual Hallucinations and Impaired Conscious Visual Perception in Parkinson Disease.
    Kurita A; Koshikawa H; Akiba T; Seki K; Ishikawa H; Suzuki M
    J Geriatr Psychiatry Neurol; 2020 Nov; 33(6):377-385. PubMed ID: 31808354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual hallucinations in Parkinson's disease: a review and phenomenological survey.
    Barnes J; David AS
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):727-33. PubMed ID: 11385004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neural correlates of the visual consciousness in schizophrenia: an fMRI study.
    Lefebvre S; Very E; Jardri R; Horn M; Yrondi A; Delmaire C; Rascle C; Dujardin K; Thomas P; Pins D
    Eur Arch Psychiatry Clin Neurosci; 2021 Jun; 271(4):661-675. PubMed ID: 32813032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual memory errors in Parkinson's disease patient with visual hallucinations.
    Barnes J; Boubert L
    Int J Neurosci; 2011 Mar; 121(3):159-64. PubMed ID: 21138396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mind-wandering in Parkinson's disease hallucinations reflects primary visual and default network coupling.
    Walpola IC; Muller AJ; Hall JM; Andrews-Hanna JR; Irish M; Lewis SJG; Shine JM; O'Callaghan C
    Cortex; 2020 Apr; 125():233-245. PubMed ID: 32058090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.